Who Follows GMO's Kumagai? Ranking Japan's Most Cross-Appointed Executives
- Yamakawa of GMO Internet Group holds director positions in eight companies.
- Executives with roles in three or more companies may face shareholder opposition.
- Non-executives with six or more directorships also face advisory opposition.
- Institutional investors analyze shareholder meeting proposals and provide voting advice.
- Tyo Keizai Online analyzes proposals to assess the reasonableness of multiple directorships.
While many Taiwanese readers may not be familiar with Japan’s directorship regulations, the issue is highly relevant to corporate governance trends in Taiwan. Japan’s recent tightening of rules on executive directorships reflects a global shift toward transparency and conflict-of-interest prevention. GMO’s Yamakawa, with director roles in eight companies, has already raised concerns among institutional investors and regulators. Whether such multi-appointments genuinely enhance efficiency or mask governance risks remains a key question.
Similar patterns are emerging in Taiwan, where directors often hold multiple positions, especially in family-owned and holding company structures. Without proper oversight and disclosure, such practices could undermine shareholder interests and company reputation. Japan’s institutional investors are playing a more active role through voting advice, and Taiwan should consider how to empower investors to participate more effectively in governance, rather than relying solely on regulations and authorities.
At the heart of corporate governance lies transparency and accountability—not just the illusion of operational efficiency.